$DCOY 4 SEC Filings

Filed On	Filing
02 Sep 2026	Form 4: Lieber Jonathan I, Director Received 2,000 shares as a grant or award
02 Sep 2026	Form 4: Pierce Frederick Ii, Chief Executive Officer Received 33,455 shares as a grant or award
02 Sep 2026	Form 4: Marschel Peter Klaus, Chief Business Officer Received 3,900 shares as a grant or award
02 Sep 2026	Form 4: Rosenblum Mark J, Chief Financial Officer Received 9,682 shares as a grant or award
02 Sep 2026	Form 4: Hibner Barbara Louise, Chief Scientific Officer Received 4,216 shares as a grant or award
02 Sep 2026	Form 4: Hanish Arnold C, Director Received 3,000 shares as a grant or award
02 Sep 2026	Form 4: Lammers Paul, Director Received 2,000 shares as a grant or award
02 Sep 2026	Form 4: Burleson Tess, Director Received 2,000 shares as a grant or award
02 Sep 2026	Form 4: McVicar William K., Director Received 3,000 shares as a grant or award
02 Sep 2026	Form 4: Gauthier Patricia G., Director Received 2,000 shares as a grant or award
02 Jan 2026	Form 4: Hanish Arnold C, Director Sold 27 shares ($17.3)
24 Nov 2025	Form 4: Hanish Arnold C, Director Bought 5,000 shares ($3.74K)
20 Nov 2025	Form 4: Rosenblum Mark J, Exec VP Finance, CFO Bought 20,000 shares ($16K)
12 Apr 2024	Form 4: Arthur David J., Director Granted 20,500 Stock Option (right to buy)
22 Feb 2024	Form 4: Rosenblum Mark J, Exec VP Finance, CFO Granted 22,500 Stock Option (right to buy)
22 Feb 2024	Form 4: McVicar William K., Director Granted 20,500 Stock Option (right to buy)
22 Feb 2024	Form 4: McCreedy Bruce J Jr., Director Granted 20,500 Stock Option (right to buy)
22 Feb 2024	Form 4: Lieber Jonathan I, Director Granted 20,500 Stock Option (right to buy)
22 Feb 2024	Form 4: Lammers Paul, Director Granted 20,500 Stock Option (right to buy)
22 Feb 2024	Form 4: Burleson Tess, Director Granted 20,500 Stock Option (right to buy)

Comments